Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. - Wikidata - awgldk - TriplyDB

Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.

Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.

http://www.wikidata.org/entity/Q33525230

about

X-ray crystal structure of the streptococcal specific phage lysin PlyC.Antimicrobial bacteriophage-derived proteins and therapeutic applications Synthetic biology of antimicrobial discovery A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa Bacteriophages and Their Immunological Applications against Infectious Threats.A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus.Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88.LysGH15B, the SH3b domain of staphylococcal phage endolysin LysGH15, retains high affinity to staphylococci.Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages.Biochemical characterization and evaluation of cytotoxicity of antistaphylococcal chimeric protein P128.Bacteriophage endolysins as novel antimicrobials.Engineered bacteriophage lysins as novel anti-infectives LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains.Lysibodies are IgG Fc fusions with lysin binding domains targeting Staphylococcus aureus wall carbohydrates for effective phagocytosis.Potential of the virion-associated peptidoglycan hydrolase HydH5 and its derivative fusion proteins in milk biopreservation.The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice Degradation of methicillin-resistant Staphylococcus aureus biofilms using a chimeric lysin.Bacteriophage PBC1 and its endolysin as an antimicrobial agent against Bacillus cereus.Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.Modeling curvature-dependent subcellular localization of the small sporulation protein SpoVM in Bacillus subtilis Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance.Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.The Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa.RETRACTED: Identification of Peptidoglycan Hydrolase Constructs with Synergistic Staphylolytic Activity in Cow's Milk.Existence of separate domains in lysin PlyG for recognizing Bacillus anthracis spores and vegetative cells.Using a Novel Lysin To Help Control Clostridium difficile Infections Determining bacteriophage endopeptidase activity using either fluorophore-quencher labeled peptides combined with liquid chromatography-mass spectrometry (LC-MS) or Förster resonance energy transfer (FRET) assays Combination Therapy of LysGH15 and Apigenin as a New Strategy for Treating Pneumonia Caused by Staphylococcus aureus.Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.A bacteriophage endolysin that eliminates intracellular streptococci Triple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureus Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuﬄing with Potent Killing Activity against Pneumococci and Related Species Antibiofilm Activities of a Novel Chimeolysin against Streptococcus mutans under Physiological and Cariogenic Conditions.Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus.

P2860

Q24623471-51C91FF7-A3DB-49BF-897D-C76B62C037CA Q26781115-D9319744-9A4B-4CB4-AD4C-2FBEA5658110 Q27001264-DE007AE9-A7E3-425C-8175-6414B5F9F323 Q27304933-6994FFA4-1668-42CE-85FE-1E4B20255079 Q28603769-D59FBCD1-2576-4457-9944-3B3F71A9B46E Q30234522-C258BFE0-E7F9-4425-9529-8215633F467B Q33797903-E38059C9-A3F7-4D7A-A68D-EAAAFF80AFEC Q33854421-1B242297-CF0B-49C0-8CB8-4C5C3DD100B3 Q33935353-8D6B4374-A3D7-4D66-88F2-48A33DDA2D3E Q34030455-96418EF9-2787-4011-9349-82A04D6A5FCD Q34296269-68C0FDB7-BB8A-4C5E-83A6-155F8FAE290C Q34298267-6BDE6213-D587-4F98-B1B6-52A8FFAB7FEB Q34303439-433B2B42-68CD-44D8-BBD5-BB4667116943 Q34349552-B397B576-F269-4213-8586-8B85EFCCD7D5 Q34487554-5727E309-4704-4653-91C6-4CB78121A50A Q34528933-D7194AAF-8D7E-4C3B-AAA3-1F860A70B91C Q34555552-31330CE1-DC09-4E25-BACA-8AB3B936B213 Q34566563-F3695604-EF02-4488-BDCF-D0E0B8C7AF0F Q34664096-9199889A-1BD3-422D-A701-6CE77CD1642D Q35151246-445427D6-C797-4A14-BA0F-09200A8DD552 Q35172146-50CAB1B6-D395-498E-A82C-6F90E5B45FA9 Q35432724-02644FD0-8D66-442E-A911-395C4B6F7507 Q35549804-0AE9718C-FCF4-4772-9F0B-2E2033199EF9 Q35751036-C2275B5E-C565-47F3-8A2A-642A8766E25C Q35827070-150AD232-4799-445F-8CFA-72BA0BD36080 Q36238470-C84279A8-4349-4C1E-91C8-299D5604D41B Q36270490-72E12704-12E6-4A5C-B655-26D47ABFE64D Q36276882-8470EEA1-59F8-4D11-8FB7-0BF49238E2C9 Q36290571-C9AA0F44-39FE-4A08-A39E-B9823EEE4137 Q36309151-3AAB632C-61F6-44CC-BD18-8F5342127782 Q36434131-162ADF02-C60D-44CC-A992-740664EEDDBF Q36676044-CE31CCFF-10F5-4017-9C8E-2C8426132E2E Q36844603-6ADCDBA6-AB54-46F8-8B5C-B1FAA682273E Q36845812-6B2638B0-2A9F-4204-B553-C479C52B5278 Q37026612-EA14BD3A-2A57-48DC-8E3C-A81EFCBA8F92 Q37072798-691F3A73-4DCD-4474-B61F-3864C0E1937B Q37131742-ECDBD78C-19D7-4183-ADFE-7C1DB1D85E59 Q37428714-08F89567-3D4E-48F4-93FB-6D82E6A18439 Q37544464-F0ED24E4-14DC-4244-873F-6F00C0ACA1C1 Q37571286-E22BFFCA-DC60-48EA-87D8-FB797D9CE4A7

P2860

Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.

http://www.wikidata.org/entity/Q33525230

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Synergism between a novel chim ...... sistant Staphylococcus aureus.

@ast

Synergism between a novel chim ...... sistant Staphylococcus aureus.

@en

Synergism between a novel chim ...... sistant Staphylococcus aureus.

@nl

type

label

Synergism between a novel chim ...... sistant Staphylococcus aureus.

@ast

Synergism between a novel chim ...... sistant Staphylococcus aureus.

@en

Synergism between a novel chim ...... sistant Staphylococcus aureus.

@nl

prefLabel

Synergism between a novel chim ...... sistant Staphylococcus aureus.

@ast

Synergism between a novel chim ...... sistant Staphylococcus aureus.

@en

Synergism between a novel chim ...... sistant Staphylococcus aureus.

@nl

P1433

Q33525230-EBD47F42-F601-4035-8345-113307CEB304

P1476

Q33525230-6A32673E-8B4F-46D6-BD77-A05E9736C5AD

P2093

Q33525230-1B569EB0-9B5F-47EC-BAEC-3D879095D33E

Q33525230-25E77A99-2AD4-40A3-83F8-7F8C28C60CDE

Q33525230-7971BCE9-B144-4473-B4E7-67EA33469B24

Q33525230-7A4F79BC-2A49-43CF-8C2D-7108E0D9E5E4

Q33525230-89652F86-5EB8-49B2-B0A5-8E4504E9553F

P2860

Q33525230-1A924DB7-1B2F-4041-88E8-087575381A37

Q33525230-1BBC893E-9D1D-4E51-85C5-8DF3F083640D

Q33525230-1CECE22D-3753-4C5D-9DD0-3554EE1C1041

Q33525230-312CB087-BEA8-4BE0-8A45-A2E1E0A9B086

Q33525230-41C22507-6468-4725-912E-6539EB1ECF7C

Q33525230-43909D9F-2870-4EFC-BD26-AAF946463FE6

Q33525230-4843511C-AE4F-4039-AA40-C46146E4C720

Q33525230-4A47A550-2964-4F23-82D7-6EC1DF3C3B28

Q33525230-4A599B3B-F6DA-484D-8827-9D9A63B9D81C

Q33525230-4C1CCC37-1EA0-4558-A3C8-F9B48DF5684C

P304

Q33525230-1A193DD8-458C-4368-B5E8-21F92938FF2A

P31

Q33525230-FB86E604-324E-40DD-A4D0-428088241F57

P356

Q33525230-355D7692-8E6A-414F-B41B-4B2CCD4B8179

P407

Q33525230-E717FC2F-B04E-44FB-AFC5-FEE549CC2DAE

P433

Q33525230-CAADAE3D-8802-4E4C-B00F-F57321B5622F

P478

Q33525230-B2758EF0-BF5C-4F48-ACE2-ECF5142A0493

P50

Q33525230-B0E389FB-DEE5-49E0-A126-FD8C2052486C

P577

Q33525230-806B436C-2043-4423-AC2A-D45D8736AD58

P5875

Q33525230-71D5C67E-A5EF-4420-9DCA-F1CDBFCBBE73

P698

Q33525230-4B1AC515-DC38-4D9D-97F3-9F975F7EDE73

P921

Q33525230-D954753F-2C7A-4A47-88B8-A997A3408C73

P932

Q33525230-AAD8EBF9-707C-45BC-A38C-FD0646553FA4

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Synergism between a novel chim ...... sistant Staphylococcus aureus.

@en

P2093

Anu Daniel

http://www.w3.org/2001/XMLSchema#string

Chad Euler

http://www.w3.org/2001/XMLSchema#string

Kenneth J Gorelick

http://www.w3.org/2001/XMLSchema#string

Peter Chahales

http://www.w3.org/2001/XMLSchema#string

Vincent A Fischetti

http://www.w3.org/2001/XMLSchema#string

P2860

Insights on Evolution of Virulence and Resistance from the Complete Genome Analysis of an Early Methicillin-Resistant Staphylococcus aureus Strain and a Biofilm-Producing Methicillin-Resistant Staphylococcus epidermidis Strain

Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium

Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme

Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia

Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks

Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity

Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin

Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges.

Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.

Peptidoglycan hydrolase fusions maintain their parental specificities

P304

1603-1612

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01625-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41088254

http://www.w3.org/2001/XMLSchema#string

P698

20086153

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus

P932

2849374

http://www.w3.org/2001/XMLSchema#string